ArticleClinical pharmacology and therapeutics2022

Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection.

Daphne M Hullegie-Peelen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.